TEFRON LTD ORD TFR (NYSE)

$ 0.46
12/01/2008 16:14
Sponsored by
Click here!
Change: -0.04 (-8.00%)
Volume: 53,114

Avg. Volume: 9881
P/E Ratio: 0
EPS (Annual): -0.52
Profit Margin:
Dividend & Yield(Annual): 73.78%
Shares Outstanding: 21,200
Institutional Shareholders: 23.29%
Last: 0.46
Change: -0.04 (-8.00%)
Prev. Close: 0.50
Open: 0.53
Day's Range: 0.42 - 0.70
52wk Range: 0.40 - 5.38
Market Value: 10,840
Beta: 1.13
12-month EPS Change: 0.00%
Total Return Last 12 Months: -89.44%
Total Return Last 3 Years: -133.74%
Total Return Last 5 Years: -85.03%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on TFR
Alert me Subscribe

Omrix Biopharma shares rise after 2Q profit jump

(NEW YORK)Shares of Omrix Biopharmaceuticals Inc. rose more than 5 percent in trading Tuesday, a day after the company announced that its second-quarter profit had doubled.READ MORE
Aug 12, 2008 7:25PM
Keywords: OMRI, TRIN, TFR

Omrix Biopharmaceuticals names Alperovitz CFO

(NEW YORK)Omrix Biopharmaceuticals Inc. late Monday named Asaf Alperovitz as chief financial officer, effective Oct. 23. Alperovitz has served as chief financial officer of Tefron Ltd. since...READ MORE
Aug 12, 2008 10:35AM
Keywords: OMRI, TFR
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement